Sauvie
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
CanadaWebsite
www.sauvieinc.comRevenue
<$5 MillionIndustry
About Sauvie
Sauvie Org Chart
Is Sauvie your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Sauvie recently announced quarterly report
Click to see if Sauvie had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Sauvie
Check if Sauvie has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sauvie launches new products
Check out if Sauvie is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Sauvie has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Sauvie, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Sauvie
Find more new buyers
Compare Similar Companies to Sauvie
Compare insights from companies similar to Sauvie, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sauvie is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sauvie is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sauvie.
Sauvie Tech Stack
A closer look at the technologies used by Sauvie
Sauvie News & Media
DBP International AB and Vivo Biopharma LLC Enter into Asset Purchase and Collaboration agreements to Develop and Commercialize a novel Glioblastoma Treatment
Double Bond Pharmaceutical International AB (publ) (“DBP”) and Vivo Biopharma LLC (“Vivo”), a wholly owned subsidiary of Sauvie Inc. (“Sauvie”) today announced that they have entered into an asset purchase, collaboration and transition agreements for DBP’s SI-053 development product and related assets. SI-053 is a locally acting formulation of temozolomide for the treatment of glioblastoma and it received Orphan Drug Designation from the European Medicines Agency in 2016. Recently, SI-053 receivSauvie Inc. Enters into an Exclusive Worldwide License Agreement to Develop and Commercialize a Nanobody-based NK Cell Engager
SHORT HILLS, N.J., Oct. 24, 2022 /PRNewswire/ -- Sauvie Inc. (the "Company"), a mission-driven biopharmaceutical company focused on sustainably building an immuno-oncology company, today announced Sauvie's subsidiary, Sauvie BiKE LLC, has entered into an exclusive license agreement with...
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Sauvie
Sauvie Inc. is developing a cutting-edge protein discovery platform that aims to revolutionize biological intelligence. The company is focused on creating a digital home for this innovative technology. While details are still forthcoming, Sauvie is poised to make significant advancements in the field. Their intended clients likely include researche... Read More